IRF3 and viral infectious disease: On the one hand, PLpro may enzymatically reduce the ISGylation of MDA5 and IRF3 genes, thus inhibiting the host response to viral infection [33]; on the other PLpro may induce the extracellular release of ISG15, thus amplifying the production and release of pro-inflammatory cytokines and chemokines in host infected cells [34].